Session Speaker

The Intravenous Laser Blood Irradiation, a new Therapeutic Approach in Immunology and Cancer Therapy
Michael Weber
Germany

The intravenous laser blood irradiation is a new method for systemic laser treatment and energy transfer to the human body. A certified system was developed in Germany in 2005 with financial support of the German government and the European Union in the field of biophotonics. For therapeutic application red, infrared, green and blue lasers are used. The laser beams are conducted by an intravenous catheter technique directly in the human blood. The photon stream applied intravenously leads to an improved microcirculation, activation of the immune system and the mitochondria. The different lasers are absorbed by the complexes of the respiratory chain in the mitochondria with increase of ATP-production and energetic stabilisation of hypoxic cells and a verifiable increase of metabolic channels.

New data showed measurable effects on tumor markers in a lot of different cancers. The effects on cancer cells can be enhanced by additional use of intravenous photosensitzers which bind to tumor cells and are activated by the lasers of different wavelengths. In new German studies Ukrain ( Nowicki Pharma, Austria ) was used as a photosensitzer, activated mainly by blue light. Tumor cells will be destroyed by reactive oxygene species. This method is called systemic photodynamic therapy ( Sys-PDT ).
New results on prostate and other cancer patients are reported.